Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nithya Krishnan

Showing results (51-60 of 55) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 55 results.
Transplantation|October 5, 2011
Human leukocyte antigen antibody-incompatible renal transplantation: excellent medium-term outcomes with negative cytotoxic crossmatchRobert Higgins, David Lowe, Mark Hathaway, et al.
Cell Death & Disease|December 16, 2017
Decitabine, a DNA-demethylating agent, promotes differentiation via NOTCH1 signaling and alters immune-related pathways in muscle-invasive bladder cancerSwathi Ramakrishnan, Qiang Hu, Nithya Krishnan, et al.
Transplantation|February 25, 2012
Human leukocyte antigen-specific antibodies and gamma-interferon stimulate human microvascular and glomerular endothelial cells to produce complement factor C4Rizwan Hamer, Guerman Molostvov, David Lowe, et al.
Transplantation Research|May 7, 2013
Campath, calcineurin inhibitor reduction and chronic allograft nephropathy (3C) study: background, rationale, and study protocolRichard Haynes, Colin Baigent, Paul Harden, et al.
The Journal of Infection|December 22, 2025
Tuberculosis incidence in solid organ transplant recipients in Europe: A multicenter TBnet cohort studyBerit Lange, Thomas Theo Brehm, Sandra M Arend, et al.
Pageof 6

Showing results (51-60 of 55) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 55 results.
Transplantation|October 5, 2011
Human leukocyte antigen antibody-incompatible renal transplantation: excellent medium-term outcomes with negative cytotoxic crossmatchRobert Higgins, David Lowe, Mark Hathaway, et al.
Cell Death & Disease|December 16, 2017
Decitabine, a DNA-demethylating agent, promotes differentiation via NOTCH1 signaling and alters immune-related pathways in muscle-invasive bladder cancerSwathi Ramakrishnan, Qiang Hu, Nithya Krishnan, et al.
Transplantation|February 25, 2012
Human leukocyte antigen-specific antibodies and gamma-interferon stimulate human microvascular and glomerular endothelial cells to produce complement factor C4Rizwan Hamer, Guerman Molostvov, David Lowe, et al.
Transplantation Research|May 7, 2013
Campath, calcineurin inhibitor reduction and chronic allograft nephropathy (3C) study: background, rationale, and study protocolRichard Haynes, Colin Baigent, Paul Harden, et al.
The Journal of Infection|December 22, 2025
Tuberculosis incidence in solid organ transplant recipients in Europe: A multicenter TBnet cohort studyBerit Lange, Thomas Theo Brehm, Sandra M Arend, et al.
Pageof 6